• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Market for Generic Biologics: Issues, Trends, and Market Potential, The

$1,500.00 – $3,000.00

Clear
SKU: KLI953906 Category: Pharmaceuticals Market Research Pages: 138
  • Description
  • Table of Contents
  • Latest reports

Description

Biologics, or biopharmaceuticals, are synthetic or recombinant versions of natural biologic substances, including proteins such as enzymes or antibodies and nucleic acids such as DNA or RNA. Generic products are non-patented chemical and therapeutic equivalents of brand name drugs. However, biogenerics are not generic biologics, because there can technically be no generic form of biologics. That is, the complex process of creating biologics, means that traditional definitions of bioequivalence used in the generic drug industry do not (or may not) apply. Industry participants are struggling with what to call these hybrid forms of biologics that will inevitably be created by the generic companies.

This report describes the complex regulatory and technical issues involved in the emerging biogeneric industry and forecasts the potential size and growth of the market for currently off-patent and soon-to-be off-patent biopharmaceuticals by analyzing likely candidates, their current market value, and any generic development underway.

Table of Contents

Chapter One: Executive Summary

  • Scope and Methodology
  • Size and Growth of the Market
  • Trends Affecting the Market
  • Market Outlook

Chapter Two: Introduction and Overview

  • Biogenerics Overview
  • Biopharmaceutical Industry and the Approval Process
  • Genetic Engineering
  • The Traditional Approval Process
  • Regulations for Biopharmaceuticals
  • History of the Prescription Generic Pharmaceuticals Industry
  • The Generic Approval Process
  • Regulation of Prescription Generic Pharmaceuticals
  • Biopharmaceutical Therapeutic Areas

Chapter Three: BioGeneric Pharmaceuticals for Expired Biologic Patents

  • The Products
  • Market Size and Growth
    • World Market
    • U.S. Market
    • Non-U.S. Market

Chapter Four: BioGeneric Pharmaceuticals for Future Expired Biologic Patents

  • The Products
  • Market Size and Growth
    • World Market
    • U.S. Market
    • Non-U.S. Market

Chapter Five: Issues and Trends

  • Overview
  • Regulatory and Legislative Issues
  • Scientific Issues
  • Patent Issues
  • Pricing Issues
  • Barriers to Entry
  • Innovator Strategies and Challenges
  • Bulk Suppliers and Contract Manufacturing
  • Bioequivalence Issues
  • International Issues

Chapter Six: Market Summary

  • Total Market Size and Forecast
  • Competitor Outlook

Chapter Seven: Corporate Profiles

  • Analiza, Inc
  • Apotex, Inc.
  • Barr Laboratories, Inc.
  • BioGeneriX AG
  • Cangene Corporation
  • Dr. Reddy’s Laboratories Limited
  • Dragon Pharmaceuticals, Inc.
  • GeneMedix plc
  • IVAX Corporation
  • Microbix Biosystems, Inc.
  • Sandoz (Novartis)
  • Sicor, Inc.
  • STADA Arzneimittel AG
  • TEVA Pharmaceutical Industries, Ltd.
  • Watson Pharmaceuticals, Inc.

Appendix A: Company Directory

Appendix B: Generic Company Directory

List of Exhibits

Chapter One: Executive Summary

  • Table 1-1: Total World Biogenerics Market Potential 2004-2008
  • Figure 1-1: The World Market Potential for BioGeneric Drugs Revenues by Current Patent Status 2004-2008
  • Figure 1-2: The World Market Potential for BioGeneric Drugs Share by Current Patent Status 2008

Chapter Two: Introduction and Overview

  • Table 2-1: Major Areas of Biopharmaceuical Treatment

Chapter Three: BioGeneric Pharmaceuticals for Expired Biologic Patents

  • Table 3-1: Marketed Biopharmaceuticals with Expired Patents
  • Table 3-2: Total World Biogenerics Market Potential for Products with Currently Expired Patents 2004-2008
  • Table 3-3: Total U.S. Biogenerics Market Potential for Products with Currently Expired Patents 2004-2008
  • Table 3-4: Total Non-U.S. Biogenerics Market Potential for Products with Currently Expired Patents 2004-2008

Chapter Four: BioGeneric Pharmaceuticals for Future Expired Biologic Patents

  • Table 4-1: Currently Marketed Biopharmaceuticals with Active Patents—Product, Maufacturer, Approval Date
  • Table 4-2: Earliest Patent Expiry Dates for Selected Biopharmaceutical Products
  • Table 4-3: 2003 Revenues of Key Branded Biopharmaceutical Products
  • Table 4-4: Currently Marketed Biopharmaceuticals with Active Patents with Known Generic Development Underway (as of May 2004)
  • Table 4-5: Cost of Treatment for Selected Biopharmaceutical Products with Active Patents
  • Table 4-6: Total World Biogenerics Market Potential for Products with Active Patents 2004-2008
  • Table 4-7: Total U.S. Biogenerics Market Potential for Products with Active Patents 2004-2008
  • Table 4-8: Total Non-U.S. Biogenerics Market Potential for Products with Active Patents 2004-2008

Chapter Five: Issues and Trends

  • Table 5-1: Estimates of Treatment Cost Per Patient of Selected Biopharmaceuticals

Chapter Six: Market Summary

  • Table 6-2: The World Market Potential for BioGeneric Drugs Revenues and
  • Growth by Current Patent Status 2004-2008
  • Figure 6-1: The World Market Potential for BioGeneric Drugs Revenues by Current Patent Status 2004-2008
  • Figure 6-2: The World Market Potential for BioGeneric Drugs Share by Current Patent Status 2008

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    World Market for Anti-infectives Volume III: The World Market for Antiviral Medications, The

    $1,875.00 – $3,750.00
  • Placeholder image

    Emerging Cancer Vaccine Market, The

    $3,500.00 – $7,000.00
  • Placeholder image

    World Market for Anti-infectives Series: Volumes I – III – Antifungals, Antibacterials and Antivirals, The

    $6,000.00 – $12,000.00
  • Placeholder image

    Cardiovascular Disease: The 45 Market in the United States for Drugs and Medical Devices

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
U.S. Market for Molecular Diagnostics, 2nd EditionFacial Cosmetic Surgery and Rejuvenation Markets
Scroll to top